1. Home
  2. SXC vs GOSS Comparison

SXC vs GOSS Comparison

Compare SXC & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunCoke Energy Inc.

SXC

SunCoke Energy Inc.

HOLD

Current Price

$6.88

Market Cap

549.5M

Sector

Industrials

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$2.16

Market Cap

615.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXC
GOSS
Founded
1960
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
549.5M
615.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SXC
GOSS
Price
$6.88
$2.16
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$10.00
$8.83
AVG Volume (30 Days)
984.7K
5.5M
Earning Date
02-17-2026
03-12-2026
Dividend Yield
6.01%
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$1,843,100,000.00
$44,051,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.94
$6.41
P/E Ratio
$10.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.24
$0.76
52 Week High
$10.08
$3.87

Technical Indicators

Market Signals
Indicator
SXC
GOSS
Relative Strength Index (RSI) 33.96 36.22
Support Level $7.98 $2.24
Resistance Level $8.43 $2.50
Average True Range (ATR) 0.34 0.22
MACD -0.10 -0.01
Stochastic Oscillator 22.62 2.48

Price Performance

Historical Comparison
SXC
GOSS

About SXC SunCoke Energy Inc.

SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: